Incyclix Bio Alternatives & Competitors
12 companies similar to Incyclix Bio — Regaining Cell Cycle Control
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
T-Therapeutics Ltd
Making T-Cell Receptor Biologics a Reality
Cambridge, United Kingdom
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Track all Incyclix Bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Biosceptre International Limited
Pioneering the development of a multi-targeted universal CAR-T system incorporating our nf...
Cambridge, United Kingdom
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
TFC Therapeutics
We are a biotechnology company focused on developing novel biologics to target and elimina...
New York, United States
Ariceum Therapeutics
Developing next-generation radiotherapeutics to visualize and treat cancer
Berlin, Germany
PhotonPharma
An immuno-oncology company unleashing the body to fight cancer
Fort Collins, United Stat...
Enlaza Therapeutics
Pioneering Covalent Biologics
San Diego, United States
Adcytherix
Building an ADC Powerhouse
Marseille, France
About Incyclix Bio
Regaining Cell Cycle Control
Development of selective CDK inhibitors, Clinical development of INX-315, Research and discovery in oncology
Cancer patients, Healthcare professionals, Oncologists, Biotech investors, Pharmaceutical researchers
Cell Cycle Control, Precision Treatments, CDK2 Inhibitor, Cancer Therapeutics, Small Molecule Inhibitors, Oncology Drug Development, Cyclin-Dependent Kinases, Tumor Types, Ovarian Cancer, Breast Cancer, Lung Cancer, Clinical Stage Biotechnology, Aberrant Proliferation, Drug Discovery, Research Triangle Park
B2B, B2D
Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Incyclix Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Incyclix Bio on 4 Jun 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
